While early-phase research has shown immense promise, the scientific community continues to gather more information, particularly regarding long-term effects, optimal dosing strategies for various research models, and potential off-target effects
Borna Vrdoljak, Departments of Pharmacology and Pathology, Medical Faculty University of Zagreb, Zagreb 10000, Croatia
Baseline scores for each dimension are shown for the two treatment groups with respect to the population norm of patients with chronic disease from the Medical Outcomes Study (31) in Figure 5
As long as it doesnt quote-hurt them, they should be able to choose. The question, of course, is whether peptides could indeed be hurting people and theres not yet enough research to make definitive claims